Cadre (CDRE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Mar, 2026Executive summary
Achieved record annual adjusted EBITDA for the third consecutive year, driven by strong demand in public safety, defense, and nuclear markets, and successful execution of strategic objectives.
Completed acquisitions of Carr's Engineering and TYR Tactical, expanding capabilities, product offerings, and international reach.
Declared the 17th consecutive quarterly dividend, with an annualized increase to $0.40 per share.
Secured major contract wins in advanced sensor technologies and blast mitigation seating, increasing backlog and supporting future growth.
Maintained a strong balance sheet, enabling disciplined investments and ongoing M&A activity.
Financial highlights
FY 2025 net sales rose to $610.3 million from $567.6 million year-over-year; Q4 2025 net sales were $167.2 million, down from $176.0 million in Q4 2024.
FY 2025 net income was $44.1 million ($1.02 per diluted share), up from $36.1 million ($0.90) in FY 2024.
FY 2025 adjusted EBITDA reached $111.7 million (18.3% margin), a record for the third consecutive year.
FY 2025 gross margin improved by 140 basis points year-over-year to 43.9%.
Q4 results were down versus last year's record Q4 due to timing shifts and distribution softness.
Outlook and guidance
FY 2026 net sales guidance is $736–$758 million, with adjusted EBITDA expected between $136–$141 million (18.5% margin).
Organic growth for public safety and nuclear businesses expected at 3%-5%.
H2 2026 expected to be stronger, with Q1 revenue similar to Q3 2025 and margins around 39%.
Capital expenditures for 2026 projected at $10–$14 million, mainly for nuclear capacity expansion.
Latest events from Cadre
- Strong Q2 2026 results and raised FY2026 outlook reflect robust growth and successful M&A.CDRE
Investor presentation - Q2 2026 net sales rose 32%, with record backlog and raised guidance on strong demand.CDRE
Q2 2026 - Record backlog and robust growth in safety and nuclear markets drive strong 2026 outlook.CDRE
Investor presentation - Supplement amends 2025 executive compensation details; all other proxy matters remain unchanged.CDRE
Proxy filing - Q1 2026 net sales up 19%, record backlog, and major acquisitions support strong outlook.CDRE
Q1 2026 - Proxy covers director elections, auditor ratification, executive pay, and governance practices.CDRE
Proxy filing - Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 2025 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update